Skip to Main Content

Paper Details

A point mutation in the heavy chain complementarity-determining region 3 (HCDR3) significantly enhances the specificity of an anti-ROS1 antibody.
Biochem Biophys Res Commun
1
2017
Author NameAffiliation
Jong Bae ParkNational Cancer Center
  • 1 - 1

Datasets

Release 1.2